CVC2.0 Demonstrating Added Value to the Corporate Bottom Line

Similar documents
Florida Venture Factbook

VENTURE CAPITAL INVESTING REACHES HIGHEST LEVEL SINCE Q WITH $13.0 BILLION INVESTED DURING Q2 2014, ACCORDING TO THE MONEYTREE REPORT

Shaking the MoneyTree TM Q Update

Forum Science & Business FCRi - EY Foundation

Shaking the MoneyTree TM Q Update

3Q13. Trends in Terms of Venture Financings in Silicon Valley. Third Quarter Fenwick. fenwick & west llp

MoneyTree Report Q PricewaterhouseCoopers National Venture Capital Association. Data provide by Thomson Reuters.

Angel Investment Groups Trends and Statistics

Creating a University Angel Group

Part of the in crowd

Financing Options and Exit Strategies

Venture Capital Research Report Q4 2017

Venture Impact. The Economic Importance of Venture Capital Backed Companies to the U.S. Economy. Third Edition

presents THE ANGEL CONNECTION

Medtech Slowdown. Life sciences venture capital funding lagged behind other industries, declining 10% in 4Q13 and 1% in 2013 over last year

Silicon Valley Venture Capital Survey Second Quarter 2018

PwC Deals $42B. Global Pharma & Life Sciences Deals Insights Q Update

Overview of Venture Equity

2017 Venture Capital Update. Bobby Franklin President & CEO, National Venture Capital Association (NVCA) January 2017

1h Fenwick. Trends in Terms of U.S. Life Science Venture Financings. First Half fenwick & west llp

Israel Venture Capital Investments Report Q3 2017

THE INSTITUTIONALIZATION OF THE PRE-IPO EQUITY MARKET

The percentage of Series A rounds declined significantly, to 12% of all deals.

Silicon Valley Venture Capital Survey Third Quarter 2017

2Q13. Trends in Terms of Venture Financings in Silicon Valley. Second Quarter fenwick & west llp

Steve Bengston

Moving Ahead. Third-quarter Technology venture capital investment increased 33 percent yearover-year. percent quarter-over-quarter.

Venture Capital Search Highlights

Understanding Venture Capital

Trends in Terms of Venture Financings In Silicon Valley (Second Quarter 2010)

Angel Financing. UNCP Entrepreneurial Summit UNCP Regional Center at COMtech Pembroke, NC 12 March Presented by:

Financing Emerging Growth Companies

Average M&A Deal Size at Highest Level Since 2004

Winter 2004/05. Shaping Oklahoma s Future Economy. Success Stories: SemGroup, SolArc Technology Yearbook

VENTURE-BACKED IPO EXIT ACTIVITY MORE THAN DOUBLES IN Q WITH STRONGEST QUARTER FOR BIOTECH OFFERINGS SINCE 2000

2017 PHILADELPHIA VENTURE REPORT

Booz & Company 30 October, Making Ideas Work. The 2012 Global Innovation 1000 Study

How attractive is the BioRegion of Catalonia for foreign investment? Guy Nohra Co-Founder and Managing Director of Alta Partners

Entrepreneurship and new ventures finance. Overview and Introduction. Prof. Antonio Renzi

The MoneyTree Report. Overview of Venture Capital Investments Second Quarter 2008

The Optimum Exits Workshop Section 3 Financing Your Company

Being an Entrepreneur in the 21 st Century

The MoneyTree Report. Overview of Venture Capital Investments Third Quarter 2009

IVC-MEITAR HIGH-TECH EXITS H1/ 2015 REPORT. IVC-Meitar 2014 Exits Report Prepared by IVC Research Center Ltd.

Financing Baltimore s Growth: Venture Capital Support for Small Companies

New Technology Ventures

Michigan venture capital pros: Region attracting attention

The latest in VC: Ripple effects of record capital availability

PricewaterhouseCoopers National Venture Capital Association. Report. Data provided by Thomson Reuters

E Profesor Tom Byers

NEW GENERATION OF VCs LEADS STARTUP CEOs BACK TO THE FOLD

Venture Capital Report

Managing Risk in my career and investing in start-ups

Venture capital - An introduction into the nature of venture capital

Donostia Enpresekin Week of Innovation

2013 venture capital trends summary

Public Policy for Angels. Angels are Important to the Economy: Public Policy Strategies to Promote More Investment in Entrepreneurial Companies

Click to edit Master title style The State of the Venture Capital Industry Click to edit Master text styles

Venture-Backed Exit Activity Shows Improved Signs of Life in Q1 2010

Venture Capital Report

VENTURE CAPITAL. Financing startup and emerging growth companies Long term/patient capital Equity financing High Risk/High Return Exits: M &A or IPO

Schedule. Monday, Nov 6 Convento do Beato

San Diego Startup Week (SDSW) STARTUP WEEK. is the region s premier catalyst for innovation, creativity & entrepreneurialism.

Venture Capital Industry Overview. Powered By:

FINC915 Venture Lab Participating Firms: FALL 2010

The size of the late-stage funding gap in Europe: research. Subscribe to our newsletter Subscribe

1- History of Silicon Valley Cluster Formation. Core Universit 1891 Stanford University founded. University-originated VB Activity

Year In Review: 2017 Edition

Mario M. Casabona Founder and General Partner Casabona Ventures, LLC Early Stage Technology Company Funding

Trends in Terms of U.S. Life Science Venture Financings. Full Year Fenwick. fenwick & west llp

VENTURE CAPITAL MONITOR

The 9 Sources of Innovation: Which to Use?

Will Stronger Borders Weaken Innovation?

SAMPLE PROGRAM AGENDA

Venture financings in 3Q12 continued to show solid price increases from their prior round, but 3Q12 was not as strong as 2Q12.

Angel Investor Networks The Power of Groups

Raising capital Healthy fundraising tension shows the market s underlying strength

Drivers of Innovation in the US High Tech Model

Information Technology: McGladrey Quarterly Private Equity Deal Flow Profile

Technology Leadership Course Descriptions

VENTURE-BACKED IPO EXIT ACTIVITY KEEPS MOMENTUM WITH BEST FULL YEAR FOR NEW LISTINGS SINCE 2007; THIRD CONSECUTIVE QUARTER FOR 20+ OFFERINGS SINCE

Session 14 Venture Finance

ECONOMIC SNAPSHOT. A Summary of the San Diego Regional Economy UNEMPLOYMENT

Venture Capital. Structuring Deals & The Investment Process

Financing Sources, Sales Pitch to Investors BARCELONA Aitana Peire Venture Valuation

FUNDS DATABASE SCOPE INCLUSION CRITERIA DATA HIGHLIGHTS

Life Sciences Outlook. New York City 2016

Peter C. Freeman has over 40 year s experience in financial management, creating financial infrastructure and raising capital for established, startup,

Understanding Asia s conglomerates

Fifth Edition. Impact. The Economic Importance of Venture Capital-Backed Companies to the U.S. Economy

PitchBook. Bet ter Data. Bet ter Decisions. 4Q 2012 Private Equity. Company Inventory. Report. Sponsored by:

Industrial Technologies. Amsterdam, June 2016 Nitan Pathak European Investment Fund

FINC915 Venture Lab Participating Firms: FALL 2009

ECONOMIC SNAPSHOT. A Summary of the San Diego Regional Economy UNEMPLOYMENT

The American Angel. January 10, 2018

Indian start-ups must compete without protection, says Deepak Shahdadpuri

STUDY BLUE PART B FUNDRAISING DECISIONS

Getting Started. This Lecture

HOW TO GET VALUE FROM THIS WEBINAR

Q INTRODUCTION VC ACTIVITY OVERVIEW. Investment and fundraising. Deal size.

Transcription:

CVC2.0 Demonstrating Added Value to the Corporate Bottom Line Jaideep Raje Managing Consultant Lux Research June 2, 2016

Agenda CVC1.0 State of the Union So, why change? Reflections on CVC2.0 2

Contents CVC1.0 State of the Union So, why change? Reflections on CVC2.0 3

Minnows no more: CVC is ascendant in the entrepreneurial ecosystem $40 $35 $30 Since 2010 CVC $ 31% CAGR CVC deal count 16% CAGR 1,018 1,204 1,408 1,299 1,600 1,400 1,200 $25 890 1,000 $20 $15 460 494 622 619 494 619 428 800 600 $10 400 $5 $0 $6 $8 $11 $9 $8 $9 $13 $12 $16 $30 $37 $12 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016* 200 0 Capital Invested ($B) Deal Count *As of 5/25/2016; Source: PitchBook 4

Minnows no more: CVC is ascendant in the entrepreneurial ecosystem 25.0% 20.0% 15.0% 13.2% U.S. CVC activity 23.5% 20.6% Over the past 20 quarters, the CVC participation in U.S. VC deals has risen roughly 12% per quarter 10.0% 5.0% 0.0% 6.7% 2011 Q1 2011 Q2 2011 Q3 2011 Q4 2012 Q1 2012 Q2 2012 Q3 2012 Q4 2013 Q1 2013 Q2 2013 Q3 2013 Q4 2014 Q1 2014 Q2 2014 Q3 2014 Q4 2015 Q1 2015 Q2 2015 Q3 2015 Q4 2016 Q1 % of Deals with CVC Involvement % of Dollars from CVCs CVC groups participated in 23.5% of deals and accounted for 20.6% of dollars deployed in first quarter of 2016 in the U.S. Source: PwC/NVCA MoneyTree Report, Data: Thomson Reuters 5

Minnows no more: CVC outstrips VC in Industrial/Energy and Biotech focus Retailing/Distribution 3% Consumer Products and Services 3% Medical Devices and Equipment 3% Financial Services 4% IT Services 5% Computers and Peripherals 2% Media and Entertainment 10% Semiconductors 1% Healthcare Services 1% Telecommunications 1% Software 33% Total U.S. CVC in 2015 $7.8 billion Industrial/Energy 16% Biotechnology 17% Source: PwC/NVCA MoneyTree Report, Data: Thomson Reuters 6

Minnows no more: CVC is spreading beyond the usual suspects Traditional powerhouses (top 10 most active CVCs since 2010) 1. Intel Capital (395) 2. GV (314) 3. Qualcomm Ventures (189) 4. Salesforce Ventures (141) 5. SoftBank Capital (115) 6. Caixa Capital Risc (109) T-7. GE Ventures (95) T-7. Comcast Ventures (95) 9. Cisco Investments (94) 10. Samsung Venture Investment (93) In 2015, 264 CVCs completed at least 1 deal (up 91% from 138 in 2005) Source: PitchBook 7

Minnows no more: Bigger deals, bigger press Global CVC Activity, 2010-2015 $60.0 $51.9 $50.0 $40.0 $30.0 $32.1 $20.0 $10.0 $2010 2011 2012 2013 2014 2015 Capital Invested Mean ($million) Pre-money Valuation Median ($million) 8

Minnows no more: CVC exits are keeping pace with investment activity $45 326 350 $40 300 $35 $30 $25 $20 137 152 179 190 185 224 235 263 250 200 150 $15 $10 $5 $0 134 115 73 $11 $12 $19 $10 $7 $12 $33 $15 $20 $39 $23 $11 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016* 100 50 0 Capital Invested ($B) Deal Count *As of 5/25/2016; Source: PitchBook 9

Contents CVC1.0 State of the Union So, why change? Reflections on CVC2.0 10

Glib dismissal of CVCs as dumb money is passé, but some criticism is still legitimate If corporates are getting back in the market, it s a market top! They are usually not great market timers in that they get in at the top, then get frustrated and sell at the bottom. That is the historical pattern of most corporate VCs. CVCs are notoriously fickle either its strategy du jour or change of the guard. Its misalignment of financial interest or lack of accountability at times, CVC even invest in competing portfolio companies to gain access to technologies. 11

Let s take a look at CVCs raison d être 12

Lux-IBF CVC Survey: All respondents emphasize strategic over financial goals Most corporate venturing organizations have both financial goals and strategic goals. How would you rate the relative importance of each for your firm? Strategic goals are paramount (though of course we can't just lose money) Strategic goals are primary, financial goals secondary Roughly even balance between financial and strategic goals Financial goals are primary, strategic goals secondary Financial goals are paramount n =40 0% 5% 10% 15% 20% 25% 30% 35% Percent of responses Source: Lux Research and International Business Forum s Future of Corporate Venturing Survey, 2015 13

Timeframe for deal impact spans a wide range, but most commonly within 2-5 years When do you expect your deals to have a commercial impact on the business? 60% 50% Estimated total percent of deals: 15% 23% 25% 21% 17% 40% 30% 20% 10% 0% Next 18 months Next 2-3 years Next 3-5 years Next 5-10 years More than 10 years n =40 Almost all deals Most deals Some deals Almost no deals Source: Lux Research and International Business Forum s Future of Corporate Venturing Survey, 2015 14

CVC s value in providing strategic growth options to the parent company is suspect In its first 5 years of prolific investing, GV has only sold 2 portfolio companies to Alphabet (ka Google) Identical to the number of companies it has sold to Yahoo and Cisco Systems Intel Capital has only sold 7 of its 259 exits to Intel Sold same number to Cisco Systems and very similar number to Microsoft Johnson & Johnson Development Corporation (JJDC) has only exited two portfolio companies to Johnson & Johnson (while selling several to numerous other major pharmaceutical and medical devices companies, including competitors, such as AztraZeneca, Amgen, Merck, Medtronic and Pfizer) Average rate of successful exits to a corporate VC investor s parent is 3% CVC is a terrible incubator 15

How do you measure impact on corporate strategy? CVC see more JDAs, fewer exits and acquisitions How often has your venturing program seen the following positive outcomes, compared to expectations? Successful exit of portfolio company Acquisitions of promising start-up companies Promising joint R&D or JDAs Products commercialized with portfolio companies Why do you need a CVC unit for a JDA? Strategic decision about growth opportunities Entering new businesses or product categories Hiring of talent n =40 Source: Lux Research and International Business Forum s Future of Corporate Venturing Survey, 2015 1 2 3 4 5 Much less often than expected About as often as expected Much more often than expected 16

A fickle partner? CVCs might be acting against self-interest 4,500 4,000 3,500 3,000 2,500 2,000 1,500 1,000 500 0 3,915 55% 60% 1,056 66% 295 68% 66% 82 29 0 1 2 3 4+ Total Deals Exit % Exit % by Number of Follow-ons Looking at the all pre-2010 CVC investments: CVCs only invest once in about 73% of cases, despite the likelihood of exit improving with follow-on investments Of these 1-time investments, nearly 2/3 rd have been in the 1 st or 2 nd round 80% 70% 60% 50% 40% 30% 20% 10% 0% 1,600 1,400 1,200 1,000 800 600 400 200 46% 57% 59% 63% 63% 66% 65% 70% 60% 50% 40% 30% 20% 10% 0 0% 1 2 3 4 5 6 7+ Successful Exit Unsuccessful Exit Success Percent Exit % by Entrance Round *As of 5/25/2016; Source: PitchBook 17

A fickle partner? Corporate culture = flighty CVC CVCs come in with about a decade of experience, and stay around 5 years and then move out, not up How long do individuals at your company typically spend in a CVC role? What is the typical subsequent career path for individuals after they leave CVC roles? Percent of responses 60% 50% 40% 30% 20% 10% 0% <1 1-2 2-3 3-5 >5 yrs n =36 R&D management Product / line of business management Strategic planning and finance Leaving the company Other Source: Lux Research and International Business Forum s Future of Corporate Venturing Survey, 2015 0% 20% 40% 60% Percent of respondents 18

CVC1.0 Here s what s broken The design of CVC today dooms the average CVC unit to the perilous fate of the 3 Ms: Missed targets Missed opportunities Mad partners 19

Contents CVC1.0 State of the Union So, why change? Reflections on CVC2.0 20

CVC is ascendant, but Source: <link, link, link> 21

A sustainable CVC unit: Where does venturing fit in the portfolio of business growth drivers? New business Novelty Corporate venturing? M&A Core/ familiar business R&D Tech scouting Business development Early-stage Lab Development stage Mature Scale 22

CVC is fundamentally attractive to entrepreneurs Source: VC characteristics valued by entrepreneurs (Upfront Ventures) 23

The innovation funding ecosystem is evolving Angels Institutional VC Corporate venturing Growth equity Government funding Innovation Public markets Impact investing Superangels Incubators Micro-VC and emerging venture managers Crowdfunding Innovation competitions Sovereign wealth and direct investment LPs 24

CVCs are decidedly skeptical on other funding sources 100% 80% 60% 40% 20% 0% In the next 5 years, what will be the most important sources of funding for emerging technologies relevant to your company? n = 38 High importance Moderate importance Low importance Not relevant Source: Lux Research and International Business Forum s Future of Corporate Venturing Survey, 2015 25

So, here s what CVC2.0 should look like Focus only on a clear strategic goal: Find and de-risk early-stage, new business opportunities Build connections for the CVC unit into the company that allow it to thrive New business Novelty Core/ familiar business Early-stage Lab Corporate venturing? R&D Tech scouting Development stage M&A Business development Mature Scale Percent of responses How long do individuals at your company typically spend in a CVC role? 60% 50% 40% 30% 20% 10% 0% <1 1-2 2-3 3-5 >5 yrs n =36 What is the typical subsequent career path for individuals after they leave CVC roles? R&D management Product / line of business management Strategic planning and finance Leaving the company Other 0% 20% 40% 60% Percent of respondents 26

So, here s what CVC2.0 should look like Do the obvious stuff consistently: Align corporate venturing strategy with your overall corporate strategy and strategic foresight to solve the evergreen problems of your customers (of today and tomorrow) Invest early, stick around, and build a mechanism to see it through to the exit Ignore the hype If everyone else is already funding it, you probably shouldn t! Take enough advantage of what you can do that s different. If a different form of nimble capital can get the job done, your money is likely better spent elsewhere 27

Thank you Jaideep Raje Managing Consultant jaideep.raje@luxresearchinc.com @JaideepRaje Lux Research B.V. De Boelelaan 32, 1083 HJ Amsterdam, The Netherlands www.luxresearchinc.com